Hi Al & all,
Froceth in Vilnius and IOZK in Cologne are two immunotherapy centres that offer (among other modes of immuno-oncological therapies) dendritic vacines that would not require fresh / frozen tumour tissue (Gliovac and DCVax-L, on the other hand, requires fresh / properly frozen tissue, which most patients including my father do not have).
Their costs are quite different though as listed below (IOZK: > EUR 70k, Froceth: EUR 10k).
I wonder if these options are worthwhile executing (subject to budget constraints) and in particular if anyone in the forum has any experience / thought / recommendation for a 72-year old GBM patient (IDH-wild type, MGMT methylated) in this context.
I also wonder what makes the two costing schemes quite different and that whether there is anyone here who benefited from these options (particularly from the Froceth immunotherapy).
IOZK: Therapy Costs | IOZK
Froceth:
"
First of all, the doctor chemotherapist together with PhD. immunologist have to examine and evaluate medical conditions of the patient and decide whether or not to apply an immunotherapy of dendritic cell vaccine (DCV) or cytokine induced killer cells (CIK).
We could arrange a teleconsultation with the patient. The price of teleconsultation is 120 euros. After that, if the doctors decide to apply a treatment of DCV or CIK, the patient (or donor) must come to Vilnius for a blood draw in order to produce the product.
So there are two products of immunotherapy:
All the treatment is applied in the clinic in Vilnius.
"
Many thanks,
Bora Y.
Froceth in Vilnius and IOZK in Cologne are two immunotherapy centres that offer (among other modes of immuno-oncological therapies) dendritic vacines that would not require fresh / frozen tumour tissue (Gliovac and DCVax-L, on the other hand, requires fresh / properly frozen tissue, which most patients including my father do not have).
Their costs are quite different though as listed below (IOZK: > EUR 70k, Froceth: EUR 10k).
I wonder if these options are worthwhile executing (subject to budget constraints) and in particular if anyone in the forum has any experience / thought / recommendation for a 72-year old GBM patient (IDH-wild type, MGMT methylated) in this context.
I also wonder what makes the two costing schemes quite different and that whether there is anyone here who benefited from these options (particularly from the Froceth immunotherapy).
IOZK: Therapy Costs | IOZK
Froceth:
"
First of all, the doctor chemotherapist together with PhD. immunologist have to examine and evaluate medical conditions of the patient and decide whether or not to apply an immunotherapy of dendritic cell vaccine (DCV) or cytokine induced killer cells (CIK).
We could arrange a teleconsultation with the patient. The price of teleconsultation is 120 euros. After that, if the doctors decide to apply a treatment of DCV or CIK, the patient (or donor) must come to Vilnius for a blood draw in order to produce the product.
So there are two products of immunotherapy:
- Dendritic cell vaccine (https://www.innovitaclinic.com/immun...-cell-vaccine/) - 7000 euros
- Cytokine induced natural killers (https://www.innovitaclinic.com/immun...duced-killers/) - 6050 euros
- Immunotherapy of dendritic cell vaccine and cytokine induced natural killers - 10 000 euros.
All the treatment is applied in the clinic in Vilnius.
"
Many thanks,
Bora Y.
Comment